Have a personal or library account? Click to login
Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer Cover

Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer

Radiology and Oncology
Volume 55 (2021): Issue 3 (September 2021)
By: Sebastjan Merlo,  Nikola Besic,  Eva Drmota and  Nina Kovacevic  
Open Access
|Aug 2021
DOI: https://doi.org/10.2478/raon-2021-0013 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 341 - 346
Submitted on: Nov 25, 2020
Accepted on: Feb 9, 2021
Published on: Aug 10, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ovarian cancer,
tumour marker,
CA-125,
primary debulking surgery,
neoadjuvant chemotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2021 Sebastjan Merlo, Nikola Besic, Eva Drmota, Nina Kovacevic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 55 (2021): Issue 3 (September 2021)Next article